Effect of a congregation-based intervention on uptake of HIV testing and linkage to care in pregnant women in Nigeria (Baby Shower): a cluster randomised trial  by Ezeanolue, Echezona E et al.
Articles
www.thelancet.com/lancetgh   Vol 3   November 2015 e692
Eﬀ ect of a congregation-based intervention on uptake of 
HIV testing and linkage to care in pregnant women in 
Nigeria (Baby Shower): a cluster randomised trial
Echezona E Ezeanolue, Michael C Obiefune, Chinenye O Ezeanolue, John E Ehiri, Alice Osuji, Amaka G Ogidi, Aaron T Hunt, Dina Patel, Wei Yang, 
Jennifer Pharr, Gbenga Ogedegbe
Summary
Background Few eﬀ ective community-based interventions exist to increase HIV testing and uptake of antiretroviral 
therapy (ART) in pregnant women in hard-to-reach resource-limited settings. We assessed whether delivery of an 
intervention through churches, the Healthy Beginning Initiative, would increase uptake of HIV testing in pregnant 
women compared with standard health facility referral.
Methods In this cluster randomised trial, we enrolled self-identiﬁ ed pregnant women aged 18 years and older who 
attended churches in southeast Nigeria. We randomised churches (clusters) to intervention or control groups, 
stratiﬁ ed by mean annual number of infant baptisms (<80 vs ≥80). The Healthy Beginning Initiative intervention 
included health education and on-site laboratory testing implemented during baby showers in intervention group 
churches, whereas participants in control group churches were referred to health facilities as standard. Participants 
and investigators were aware of church allocation. The primary outcome was conﬁ rmed HIV testing. This trial is 
registered with ClinicalTrials.gov, identiﬁ er number NCT 01795261.
Findings Between Jan 20, 2013, and Aug 31, 2014, we enrolled 3002 participants at 40 churches (20 per group). 
1309 (79%) of 1647 women attended antenatal care in the intervention group compared with 1080 (80%) of 1355 in the 
control group. 1514 women (92%) in the intervention group had an HIV test compared with 740 (55%) controls 
(adjusted odds ratio 11·2, 95% CI 8·77–14·25; p<0·0001).
Interpretation Culturally adapted, community-based programmes such as the Healthy Beginning Initiative can be 
eﬀ ective in increasing HIV screening in pregnant women in resource-limited settings.
Funding US National Institutes of Health and US President’s Emergency Plan for AIDS Relief.
Copyright Ezeanolue et al. Open Access article published under the terms of CC BY-NC-ND.
Introduction
Sub-Saharan Africa has the highest burden of HIV/AIDS 
in the world. Although countries in sub-Saharan Africa 
account for 13% of the world population, they are home 
to 71% of people living with HIV worldwide. Owing to a 
plethora of biological, cultural, and economic factors, 
women are disproportionately aﬀ ected by HIV and 
represent more than half of all adults living with HIV in 
sub-Saharan Africa.1
Although mother-to-child transmission of HIV has 
almost been eliminated in many high-income countries, 
it is an important source of new HIV infection in sub-
Saharan African countries. According to the 2014 report 
of the Joint United Nations Programme on HIV/AIDS 
(UNAIDS),1 sub-Saharan Africa accounted for 87% of the 
1·5 million pregnant women living with HIV and 91% of 
children living with HIV worldwide. Despite improved 
eﬀ ort and the availability of simple, relatively inexpensive, 
and highly eﬀ ective antiretroviral regimens for 
prevention of mother-to-child transmission of HIV 
(PMTCT), 32% of pregnant women did not receive 
antiretroviral therapy (ART) for PMTCT in 2014, 
resulting in an estimated 210 000 new infections in 
children.1
Nigeria is one of 21 priority countries in sub-Saharan 
Africa that, together with India, accounts for 90% of 
pregnant women infected with HIV. In 2013, Nigeria had 
an HIV testing rate of less than 20% in pregnant women 
and accounted for 26% of all new infections in children 
in the 21 countries.1–3 Identiﬁ cation of HIV-infected 
pregnant women through routine HIV screening is a 
crucial step needed to initiate interventions designed for 
PMTCT. At present, most pregnant women access clinics 
through the health-care system to undertake HIV 
screening and receive available PMTCT interventions. 
Such a clinic-based approach is challenging when only 
35% of deliveries occur in hospitals and only 2·9% of 
health-care facilities have eﬀ ective PMTCT programmes.4 
Thus, ﬁ nding new approaches to translate evidence-
based interventions in PMTCT to sustainable 
community-based programmes is imperative to realise 
the WHO/the US President’s Emergency Plan for AIDS 
Relief (PEPFAR) goal of eliminating new paediatric HIV 
infections by 2015.2
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Ranked highly among 53 other nations in church 
attendance, Nigeria has an extensive network of 
faith-based institutions, and faith plays an important part 
in the social life of Nigerians. Religious leaders in Nigeria 
are knowledgeable about HIV and can harness their 
position for HIV prevention.5–7 Building on this 
background, we developed the Healthy Beginning 
Initiative (HBI), a culturally adapted, family-centred 
approach that relies on the widely distributed religious 
infrastructure and church-based community networks to 
promote individual testing, tracking, and retention of 
participants.
Research in context
Evidence before the study
We searched PubMed, Ovid MEDLINE, Web of Science, the 
Cochrane Database of Systematic Reviews, the Cochrane 
Central Register of Controlled Trials, and Database of Abstracts 
of Reviews on Eﬀ ects for articles published between 
Jan 1, 2000, and Dec 31, 2014, on community-based (including 
congregation or faith-based) interventions to increase HIV 
testing in pregnant women. To maximise sensitivity, we did not 
use any methodological ﬁ lters in the initial search and used the 
following broad MeSH terms “adult”, “pregnancy”, “women”, 
“HIV testing”, ”barriers to PMTCT”, “Africa south of the Sahara”, 
“female”, “HIV infections/prevention & control”, “HIV 
infections/transmission”, “prenatal diagnosis/statistics & 
numerical data”, “prenatal care/statistics & numerical data”, 
“prenatal care/statistics & numerical data”, and “counseling/
methods”. We narrowed our search in the identiﬁ ed articles 
using the search terms “HIV”, “HIV-exposed infants”, “case 
ﬁ nding”, “children”, “community health workers”, “linkage to 
care”, “pediatrics”, “community-based interventions”, 
“faith-based interventions”, “church; congregation”, and “HIV 
screening and HIV testing”. We examined systematic reviews 
and meta-analyses and other articles that met the following 
selection criteria: randomised controlled trials, cluster 
randomised controlled trials, controlled clinical trials, controlled 
before-and-after studies, and interrupted time series studies 
that investigated the comparative eﬀ ects of community-based 
interventions to increase HIV testing in pregnant women versus 
other approaches. Our clinical librarian ran the searches, two 
authors selected studies, assessed methodological quality, and 
extracted data. Disagreements were resolved by repeated 
review, discussion, and consensus of all authors.
Williams and colleagues did a review of congregation-based 
programmes to address HIV/AIDS: elements of successful 
implementation, published in 2011. Williams and colleagues 
identiﬁ ed early involvement of the congregation during both 
design and implementation as a major key factor to success. 
Gulaid and colleagues published another review on promising 
practices in community engagement for the elimination of new 
HIV infections in children in 2012. Evidence from this review 
shows that increased engagement with community and 
faith-based organisation that is participatory is needed for an 
eﬀ ective outcome. Similarly, Marcos and colleagues published a 
review on community strategies to improve care and retention 
along the prevention of mother-to-child transmission of HIV 
(PMTCT) cascade in 2012 in which they found nine articles that 
documented statistically signiﬁ cant improvement in key HIV 
prevention strategies including HIV testing. None of these 
studies used a randomised and controlled design. In July, 2013, 
Suthar and colleagues published a systematic review and meta-
analysis of community-based approaches, which concluded 
that interventions such as cash transfers, home-based testing, 
and mobile testing were eﬀ ective in promoting uptake of HIV 
testing. Suthar and colleagues concluded that some of the 
major challenges with these approaches have been the absence 
of several testing opportunities and losses to follow-up after 
testing and sustainability. More importantly, despite the wide 
availability of congregation centres and faith-based 
organisations (including churches, mosques, and other worship 
centres) in many resource-limited settings, few experimental 
studies have compared such avenues for testing with health 
facilities that are often unavailable in hard-to-reach 
communities. Suthar and colleagues oﬀ er many opportunities 
for testing and follow-up.
Added value of this study
HIV counselling and testing is an important entry point for 
most forms of HIV prevention and control including PMTCT. 
Although barriers to HIV testing have been identiﬁ ed at the 
patient, provider, and health systems levels, barriers at the 
health system level have been identiﬁ ed to have the most 
adverse eﬀ ect on HIV testing in pregnant women. Although 
several studies have tested the eﬀ ectiveness of single 
interventions on uptake of HIV testing in pregnant women, few 
randomised studies have tested a framework that identiﬁ ed 
pregnant women early, implemented an intervention with an 
integrated testing approach (HIV plus other conditions to 
reduce stigma associated with HIV-only test approaches), and 
used a systematic follow-up mechanism.
Implications of all the available evidence
Findings from this study show that, as the US President’s 
Emergency Plan for AIDS Relief (PEPFAR) shifts its emphasis 
from an emergency response to a country-owned approach, 
countries will need to build on existing socially accepted 
community-based infrastructures to implement culturally 
adapted, community-driven, and sustainable approaches that 
can substantially reduce HIV transmission and diminish its 
public health importance in low-income countries. Nigeria is 
one of 22 countries that account for 90% of pregnant women 
living with HIV and is one of only four in these countries with 
an HIV testing rate of less than 25% in pregnant women. 
Nigeria alone accounted for 26% of new child infections in 
2013. There is a dearth of community-based interventions 
targeted at this problem in countries with very low HIV testing 
rate in pregnant women.
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We did a cluster randomised trial of 40 churches in 
southeast Nigeria. We considered randomising each 
patient, but the likelihood of contamination posed a 
threat to internal validity; thus, individual pregnant 
women were nested within the church. The communities 
where the churches were located had similar ethnic group 
composition, culture, language, and church attendance. 
We also considered a crossover design, but the possibility 
of withdrawing an intervention if it was eﬀ ective would 
make this design problematic. We aimed to identify 
whether pregnant women randomised to the intervention 
would have a higher rate of HIV testing and receipt of 
ART than those randomised to the control group.
Methods
Trial design and participants
We did a two-arm cluster randomised trial in Enugu 
State in southeast Nigeria, designed to assess the eﬀ ect 
of a congregation-based HBI that provided free, 
integrated on-site laboratory tests during a church-
organised baby shower (a reception held in honour of a 
pregnant woman where she plays pregnancy-related 
games and receives gifts from friends, usually, items she 
would need during delivery or immediately after birth) as 
the intervention group versus a clinic-based referral 
approach as the control group on the rate of HIV testing 
and receipt of ART in pregnant women.
We selected Enugu State in southeast Nigeria for 
several reasons. First, its population is culturally and 
ethnically homogeneous and predominately Christian, 
with church attendance approaching 90%.5,6 Second, the 
overall state’s HIV seroprevalence of 5·1% is close to the 
national average of 4·1%. Third, the participating 
churches were widely distributed and represented 
variations in the prevalence rate of HIV across the state 
of 4–8% (mean 6%).
Randomisation was done at the level of the churches 
(clusters) and individuals were recruited from the 
congregations.
We assessed 200 churches and collected data on infant 
baptism for the 3 years preceding this study (2010, 2011, 
and 2012). Infant baptism was used as an indirect 
measure of the potential number of pregnant women in 
the churches. Churches eligible for randomisation must 
have had at least 20 infant baptisms every year for the 
past 3 years. In most cases, we selected one church in 
each community to maintain a distance between 
participating sites. Most of the communities were at least 
5 km apart with some as far as 20 km (12·5 miles) apart. 
For some churches assessed but not selected because of 
their small size (fewer than 20 baptisms per year) but in 
close proximity to a selected site (and most times with 
the same pastor as the primary site), pregnant women 
were allowed to participate in the HBI through the 
primary sites. These women were included in the total 
number of women randomised since they were recruited 
through the primary sites. Self-identiﬁ ed pregnant 
women 18 years or older who attended any of the study 
sites were eligible to participate. Women were encouraged 
to participate with their male partners, but could still 
participate if their male partner chose not to take part.
Every Sunday, the priest asked pregnant women and 
their male partners in the congregation to step to the 
altar for prayers. He prayed for a healthy pregnancy, 
successful delivery, and encouraged pregnant women to 
seek care at a health facility during their pregnancy. He 
introduced HBI and the study team as a programme 
supporting pregnant women in the congregation during 
pregnancy and described the programme’s objectives. 
Pregnant women and their male partners were 
encouraged to participate.
We focused on a congregation-based intervention 
because such interventions have been used eﬀ ectively in 
health promotion in communities in which faith has a 
substantial role, such as Nigeria, with 87% of people 
reporting religious service attendance at least once 
a week.5,6,8–12 Faith-based organisations are already 
involved in general HIV education and awareness in 
Nigeria and their role increased with implementation of 
the 2010–15 National Strategic Framework.7,13,14
For this cluster randomised trial, the funding agencies 
mandated that we have a local PEPFAR-supported 
partner working in the area of the proposed research. 
Our local partner, Prevention, education, treatment, 
Training and Research-Global Solutions (PeTR-GS), 
working with Sunrise Foundation, a local non-
governmental organisation, did training workshops for 
all study staﬀ  and church-based volunteer health advisers. 
The organisations received training on the study protocol, 
including how to obtain informed consent, data collection 
forms, and conﬁ dentiality. Additionally, study staﬀ 
received information on HIV counselling, delivery of 
HIV test results, and post-test counselling. Although 
priests were not actively involved in the main 
intervention, they received basic information on HIV 
transmission, mother-to-child transmission, PMTCT, 
and HIV counselling methods.
This study was approved by the Institutional Review 
Board of the University of Nevada, Reno, and the 
Nigerian National Health Research Ethics Committee. 
Randomisation and masking
Recruitment occurred at the level of the churches and 
then participants, whereas randomisation occurred only 
at the church level. Churches were selected and ranked 
according to size on the basis of mean annual number of 
infant baptisms (as a proxy for the number of pregnant 
women) and randomly assigned to either the intervention 
group or the control group. Randomisation of churches 
occurred 1:1 in four cohorts of ten churches after the 
ranking order (largest to smallest), stratiﬁ ed by number 
of infant baptisms (<80 vs ≥80). Assignment of smaller 
churches to the closest coordinating churches was pre-
speciﬁ ed to avoid random assignment by participants. 
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The sequence of randomisation was generated by the 
study biostatistician (WY) and kept in a sealed opaque 
envelope away from the study sites.17 Once the sites were 
recruited and baseline information on churches collected 
(eg, type and size of congregation), the sites were 
informed of their randomisation group and assigned a 
code. Participants followed the randomisation of the 
church they attend. Because of the nature of the 
intervention, it was impossible to mask the participants, 
community health nurses, volunteer health advisers, and 
study coordinators to the group assignment.
Procedures
 For participants in churches randomised to the 
intervention group, baby showers were held one Sunday 
every month. Free integrated laboratory tests were oﬀ ered 
to pregnant women during the baby shower, including 
tests for haemoglobin, malaria, sickle-cell genotype, HIV, 
hepatitis B, and syphilis. This integrated testing was 
designed to reduce stigma associated with HIV-only 
testing. Participants were provided with information on 
the six conditions included in the integrated tests and 
also received a Mama Pack provided by the church and 
distributed by their male partner or by the clergy. The 
Mama Pack contained basic essentials for a pregnant 
woman during delivery, including sanitary pads, a clean 
razor blade, alcohol, and gloves. The pack was given to all 
participating pregnant women bearing in mind that less 
than 50% of them would deliver in a health facility. 
Women identiﬁ ed as HIV-positive were linked to PeTR-
GS’s comprehensive HIV programme. One advantage of 
this approach was avoidance of duplicate testing by 
providing copies of HIV test results to participants to 
make available to staﬀ  at health facilities where they 
attended prenatal care. On-site HIV testing data and 
health facility data were used to conﬁ rm HIV testing and 
receipt of ART for participants in intervention churches.
Participants completed a post-delivery questionnaire 
to ascertain and document HIV testing during pregnancy 
and pregnancy outcome at a baby reception held every 
2–3 months (pregnant women only needed to attend the 
reception  once  after giving birth) to celebrate births 
with baby gifts and refreshments. The reception also 
provided an opportunity for follow-up with women 
needing ongoing care post delivery.
 Prayer sessions, baby showers, and baby receptions 
were done in churches randomised to control groups 
similar to churches in intervention groups with the 
exception that the intervention (health education on 
health conditions and on-site integrated laboratory 
testing) was not provided during baby showers. 
Participants in control group churches were encouraged 
to attend prenatal care at the health facilities where they 
had access to HIV testing, as is the usual practice. The 
health facilities were partners in the research 
through collaboration with our local PEPFAR-
supported partner PeTR-GS. Participants completed an 
investigator-administered questionnaire to collect 
information on HIV testing and were asked to bring 
copies to research staﬀ . Participants in control churches 
were made aware that their laboratory tests would be 
conﬁ rmed with health facilities.
Participants in both intervention and control groups 
received three study visits: one at baseline (recruitment), 
one during the baby shower, and one at 6–8 weeks after 
delivery for the baby reception.
Outcomes
The primary outcome was conﬁ rmed HIV testing during 
pregnancy. This outcome was selected to determine the 
diﬀ erence in HIV testing between the intervention and 
control groups and deﬁ ne the predictors for such testing. 
HIV testing in women in churches randomised to the 
control group were conﬁ rmed at the health facility where 
pregnant women reported prenatal care. Although we 
were aware of the potential limitations with conﬁ rming 
HIV test results at health facilities, we were also 
conscious of the unreliability of self-reported testing. In 
view of our conﬁ dence in our ability to conﬁ rm most 
HIV tests done at surrounding health facilities, we chose 
to use conﬁ rmed HIV test for both groups as the primary 
outcome measure.
The secondary outcomes were rate of PMTCT completion 
in HIV-infected pregnant women measured by linkage to 
care and receipt of ART for HIV-infected pregnant women, 
and the rate of HIV testing in male partners.
Statistical analysis
Two important sample size estimates were used. The ﬁ rst 
was the number of pregnant women, and the second was 
the number of churches, with the pregnant women nested 
within the churches. Power calculations were done using 
the PASS 11 module titled inequality tests for two 
proportions in a cluster randomised design, which 
implements the methods of Donner and Klar.15 This power 
calculation module estimates power for simple two-sample 
binomial tests for data collected in clusters with non-zero 
intra-cluster correlation (ICC). With ICC at 0·10, we would 
need a sample size suﬃ  cient to recruit at least 140 women 
infected with HIV. After considering factors such as HIV 
prevalence rate and dropout rate in women, the sample 
size designed was roughly 2700 total pregnant women 
(1350 per group). A detailed sample size calculation and 
analysis plan has been described previously.16
Our hypothesis test for diﬀ erences in two binomial 
proportions at follow-up and data were analysed with the 
χ² test and t tests. The χ² statistic was used to assess 
diﬀ erences in HIV-test proportions. Student’s t test was 
used to assess diﬀ erences in continuous data. Multilevel 
analysis generalised linear mixed models (GLIMMIX) 
were implemented with that procedure with a logit link 
function and the binomial distribution. These models are 
multilevel, allowing incorporation of covariates and 
confounders for the individual level (such as age, education 
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level, and previous HIV testing) and cluster level (church) 
covariates and confounders, such as size of church and 
congregation type (Anglican or Catholic). Adjusted odds 
ratios (aORs) between HIV-tested and HIV-non-tested 
women were obtained by controlling the previously 
mentioned covariates and potential confounding factors. 
All analyses were done with SAS version 9.4 and statistical 
signiﬁ cance was set as p<0·05. This trial is registered with 
ClinicalTrials.gov, identiﬁ er number NCT 01795261.
Role of the funding source
The funding agencies of the study had no role in the 
study conception, design, data collection, data analysis, 
data interpretation, or writing of the report. The 
corresponding author had full access to all the data in the 
study and had ﬁ nal responsibility for the decision to 
submit for publication. All authors vouch for the 
completeness and accuracy of data and data analyses and 
for the ﬁ delity of the study to the protocol.
Results
We began enrolment on Jan 20, 2013, and completed it 
by Sept 29, 2013. Follow-up of enrolled participants was 
completed on Aug 31, 2014. Of 200 churches assessed for 
eligibility, we selected 40 on the basis of being centrally 
located in the community and having at least 20 infant 
baptisms every year for the past 3 years. 20 were 
randomly assigned to the intervention group and 20 to 
the control group. An additional 44 smaller churches 
close to coordinating intervention churches were 
assigned to the intervention group and an additional 
23 smaller churches close to coordinating control 
churches were assigned to the control group via a spoke 
and wheel approach. Of the 3047 pregnant women 
enrolled across the 40 churches and their linked satellite 
churches, 45 participants were excluded from the ﬁ nal 
analysis (ﬁ gure). 19 women were of conﬂ icting age in 
the predelivery and post-delivery questionnaire, 
suggesting that they were younger than the study 
required age of 18 years. Thus, 3002 enrolled participants 
were included in the ﬁ nal analysis (ﬁ gure). Results 
showed that the observed ICC was 0·14, which suggests 
that clustering eﬀ ects existed and parishioners within 
the same church could be expected to show correlations. 
Therefore, GLIMMIX procedures with logit link function 
and binomial distribution were implemented using a 
logit link function and the binomial distribution.
In general, participants from both control and 
intervention groups had similar demographics, including 
family size, marital status, number of previous 
pregnancies, antenatal care attendance during pregnancy, 
and distance to the nearest health facility (table 1). Some 
demographic factors diﬀ ered signiﬁ cantly. For example, 
the control group were slightly older than the intervention 
group, and were more likely to have tertiary-level 
education, be in full-time employment, reside in urban 
areas, and have previously tested for HIV.
Table 2 shows rates of HIV testing between control 
group and intervention group, and between related 
factors. 1514 (92%) of 1647 pregnant women in the 
intervention group had an HIV test compared with 
740 (55%) of 1355 in the control group. Factors associated 
with having signiﬁ cantly higher HIV testing rate were 
full-time or part-time employment compared with 
unemployment, age younger than 35 years at ﬁ rst 
pregnancy, and low number of previous pregnancies.
Table 3 shows the odds ratios after adjustment for all 
demographic factors and other potential predictors for 
having no HIV testing in pregnant women, so we can 
determine factors that were barriers to testing. We 
wanted to present the group at risk (not being tested) in 
order to locate the target population for the intervention 
in the future. The odds of pregnant women not being 
HIV tested were 11 times higher in the control group 
than in the intervention group (aOR 11·18, 95% CI 
8·77–14·25; p<0·0001) after controlling for age, 
educational level, employment, area of residence, age at 
ﬁ rst pregnancy, number of previous pregnancies, and a 
history of previous HIV testing. Other signiﬁ cant or 
marginally signiﬁ cant factors for not getting an HIV 
test include unemployment, older age at ﬁ rst birth, 
Figure: Trial proﬁ le
*Selected church has to be centrally located in the community and had at least 20 infant baptisms done each year for 
the past 3 years. †Additional 44 smaller churches close to coordinating churches were assigned to intervention group 
and an additional 23 smaller backup churches close to coordinating churches were assigned to control group. These 
smaller churches follow the randomisation group of the main coordinating church using a spoke and wheel approach.
Enrolment 
Cluster randomisation
160 backup churches 
200 churches in 40 communities
assessed for eligibility
40 churches selected based on 
location and size*
22 participants removed from
the analysis
2 withdrew
11 relocated 
4 died
5 had age discrepancy
23 participants removed from 
the analysis
3 withdrew 
3 relocated 
3 died
4 had age discrepancy
1377 pregnant females recruited from control 
group churches
20 randomised to control group†
1670 pregnant females recruited from intervention 
group churches
20 randomised to intervention group†
1647 pregnant women included in the analysis 1355 pregnant women included in the analysis
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high number of previous births, and no previous HIV 
testing.
73 (2%) of 3002 women in this study had a positive 
HIV test (table 4) and thus we did not reach the expected 
level of 140 HIV-positive pregnant women. Prevalence of 
HIV did not diﬀ er between groups. Women in the 
intervention group were more likely to be linked to care 
before delivery than were those in the control group 
(OR 6·2, 95% CI 2·14–18·25; p<0·0001) and were more 
Intervention 
group (n=1647)
Control group 
(n=1355)* 
Total 
(n=3002)
Mean (SD) age 
(years)
29·3 (5·9) 29·7 (5·8) 29·7 (5·8)
Age group (years)
16–24·9 377 (23%) 288 (21%) 665
25–34·9 962 (58%) 831 (61%) 1793
≥35 283 (17%) 235 (17%) 518
Marital status
Divorced 0 2 (0·15%) 2
Married 1531 (93%) 1278 (94%) 2809
Separated 8 (0·5%) 7 (0·5%) 15
Single 108 (7%) 68 (5·02%) 176
Education level
None or primary 448 (27%) 330 (24%) 778
Secondary 950 (58%) 741 (55%) 1691
Tertiary 235 (14%) 277 (20%) 512
Employment
Full-time 573 (35%) 506 (37%) 1079
Part-time 401 (24%) 270 (20%) 671
Unemployed 632 (38%) 567 (42%) 1199
Number of people in family
≤2 257 (16%) 227 (17%) 484
3–6 1135 (69%) 935 (69%) 2070
≥7 220 (13%) 179 (13%) 399
Distance to health facility
0–5 km 529 (32%) 486 (36%) 1015
5–10 km 629 (38%) 520 (38%) 1149
10–15 km 295 (18%) 211 (16%) 506
>15 km 172 (10%) 121 (9%) 293
Residency area
Rural 1276 (77%) 880 (65%) 2156
Urban 356 (22%) 466 (34%) 822
Age at ﬁ rst pregnancy (years)
<24·9 1044 (63%) 805 (60%) 1849
25–34·9 489 (30%) 474 (35%) 963
≥35 17 (1%) 27 (2%) 44
0 233 (14%) 168 (12%) 401
Number of previous pregnancies
1–3 875 (53%) 758 (56%) 1633
≥4 448 (27%) 377 (28%) 825
Did mother receive antenatal care?
No 338 (21%) 275 (20%) 613
Yes 1309 (79%) 1080 (80%) 2389
Self-reported previous HIV testing
No 646 (39%) 354 (26%) 1000
Yes 1001 (61%) 1001 (74%) 2002
*In this group there was one participant with unknown age.
Table 1: Baseline characteristics
Participants HIV tested p value
Conﬁ rmed HIV test <0·0001
Control 1355 740 (55%) ··
Intervention 1647 1514 (92%) ··
Age group (years) 0·753
<24·9 665 492 (74%) ··
25–34·9 1793 1350 (75%) ··
≥35 518 392 (76%) ··
Marital status 0·615
Divorced 2 2 (100%) ··
Married 2809 2114 (75%) ··
Separated 15 10 (67%) ··
Single 176 128 (73%) ··
Education level 0·448
None or primary 778 576 (74%) ··
Secondary 1691 1272 (75%) ··
Tertiary 512 395 (77%) ··
Employment 0·017
Full-time 1079 827 (77%) ··
Part-time 671 522 (78%) ··
Unemployed 1199 870 (73%) ··
Number of people in 
family
0·736
≤2 484 359 (74%) ··
3–6 2070 1560 (75%) ··
≥7 399 305 (76%) ··
Distance to health 
facility
0·277
0–5 km 1015 758 (75%) ··
5–10 km 1149 854 (74%) ··
10–15 km 506 394 (78%) ··
>15 km 293 229 (78%) ··
Residency area 0·260
Rural 2156 1635 (76%) ··
Urban 822 607 (74%) ··
Age at ﬁ rst 
pregnancy (years)
0·013
<24·9 1849 1370 (74%) ··
25–34·9 963 752 (78%) ··
≥35 44 28 (64%) ··
Number of previous 
pregnancies
0·009
0 401 326 (81%) ··
1–3 1660 1229 (74%) ··
≥4 798 607 (76%) ··
Self-reported 
previous HIV testing
0·051
No 1000 729 (73%) ··
Yes 2002 1525 (76%) ··
Table 2: Predictors of HIV testing in pregnant women
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likely to access care and receive ART during pregnancy 
(2·8, 1·02–4·79; p=0·042). 61 (84%) of 73 women were 
accessing care at follow-up with no signiﬁ cant diﬀ erence 
between groups (table 4).
Discussion
Our study ﬁ ndings show that a culturally adapted, 
congregation-based approach delivered by trained 
volunteer health advisers can be used eﬀ ectively to 
increase HIV testing in pregnant women. HIV 
counselling and testing is an important entry point for 
most forms of HIV prevention and control including 
PMTCT. Although barriers to HIV testing have been 
identiﬁ ed at the patient, provider, and health systems 
levels, barriers at the health systems level have been 
found to have the most adverse eﬀ ect on HIV testing in 
pregnant women.18,19
Data from Nigeria suggest that in 2013, only 17·1% of 
women aged 15–49 years received an HIV test in the past 
12 months and knew their result.3 Absence of knowledge, 
low perception of personal risk, access, cost, stigma, and 
the fact that most women do not access prenatal care 
early in pregnancy are commonly identiﬁ ed barriers.20–22 
HBI was designed to overcome these barriers. Our 
ﬁ nding is consistent with other studies showing that well 
developed community-based approaches that decentralise 
testing beyond health facilities and consistently made 
HIV tests available in environments that reduce these 
barriers23–25 have led to increased HIV testing.26–30
We believe that several factors contributed to the 
magnitude of the eﬀ ect seen in our study with regard to 
HIV testing. For example, prayer sessions were useful for 
early identiﬁ cation of pregnant women. These sessions 
provide multiple opportunities to oﬀ er HIV counselling 
and testing; the integrated and on-site approach to 
laboratory testing provided during church—organised 
baby showers were reported by participants as a 
substantial factor in the reduction of stigma associated 
with the HIV-only testing approach; involvement of male 
partners (who presented the Mama Packs to their 
spouses) removed the preconception of a women-only 
intervention and presented the baby showers as a family-
oriented programme. Male involvement has been shown 
to be a crucial factor in pregnant women’s acceptance of 
HIV testing.31
The strength of our study includes the fact that it took 
into consideration several factors that might aﬀ ect HIV 
testing in Nigeria. Considering the role of faith for 
Nigerians, we collaborated with faith-based organisations 
that have well established social networks and are already 
involved in eﬀ orts to address HIV/AIDS in the study 
communities.32 Most communities in Nigeria have at 
least one worship centre even when there are no 
accessible health facilities. Studies show that church-
based clinics and hospitals play a signiﬁ cant part in 
prenatal care and deliveries for pregnant women, and 
that priests rank highly among people to whom a 
pregnant woman is most likely to disclose her HIV 
status.7 We identiﬁ ed and used evidence-based elements 
of a successful programme in communities where faith 
has a prominent role.33,34
Churches were used as venues to identify pregnant 
women, implement the intervention, and for post-delivery 
follow-up, and thus served as the study venue. This 
approach is similar to the use of national chain  pharmacies 
for inﬂ uenza immunisation in the USA.35 These 
neighbourhood stores are used because they are easily 
accessible, widely distributed, and as highly patronised as 
worship centres in most resource-limited settings. HBI is 
being adapted for implementation in mosques in northern 
Nigeria and Hindu temples in India. We expect to see a 
similar result in India and Nigeria because these venues 
serve a similar function as the churches or neighbourhood 
stores in the USA. Although community-based testing 
has been successfully used for HIV testing in our study 
environment, it was associated with substantial loss to 
follow-up as individuals with positive test results could not 
be identiﬁ ed owing to absence of identifying information 
such as social security numbers or government-issued 
identiﬁ cation with addresses.
 Adjusted OR* (95% CI) p value
Control vs intervention 11·180 (8·77–14·25) <0·0001
Age group: ≥35 years vs <24·9 years 1·129 (0·76–1·68) 0·552
Age group: 25–34·9 years vs <24·9 years 1·008 (0·76–1·34) 0·958
Education level: secondary vs none 0·982 (0·76–1·26) 0·888
Education level: tertiary vs none 0·870 (0·608–1·25) 0·445
Working: part-time vs full-time 0·964 (0·73–1·27) 0·795
Working: unemployed vs full-time 1·264 (1·01–1·59) 0·045
Distance to health-care facility: 5–10 km vs 0–5 km 1·159 (0·76–1·40) 0·212
Distance to health-care facility: 10–15 km vs 0–5 km 1·159 (0·92–1·46) 0·835
Distance to health-care facility: ≥15 km vs 0–5 km 1·033 (0·76–1·40) 0·895
Household size: 4–6 vs ≤3 0·801 (0·58–1·11) 0·177
Household size: ≥7 vs ≤3 0·731 (0·47–1·13) 0·158
Living area: urban vs rural 0·833 (0·66–1·06) 0·138
Age of ﬁ rst pregnancy group: ≥35 years vs <24·9 years 1·040 (0·44–2·49) 0·929
Age of ﬁ rst pregnancy group: 25–34·9 years vs <24·9 years 0·748 (0·58–0·97) 0·025
Number of previous births: 1–3 vs 0 1·657 (1·16–2·37) 0·006
Number of previous births: ≥4 vs 0 1·443 (0·93–2·23) 0·099
Self-reported previous HIV testing: yes vs no 1·711 (1·36–2·16) <0·0001
 *Adjusted ORs were based on multilevel analysis generalised linear mixed models with covariates of demographics, 
previous birth, and previous HIV testing.
Table 3: Adjusted odds ratio (OR) for no HIV testing in pregnant women
Intervention 
group (n=41)
Control group 
(n=32)
Adjusted odds 
ratio (95% CI)
Total 
(n=73)
Linked to care before delivery 34 (83%) 14 (44%) 6·2 (2·14–18·25) 48 (48%)
Antiretroviral therapy during pregnancy 24 (65%) 12 (40%) 2·8 (1·02–4·79) 36 (54%)
Currently accessing care 33 (81%) 28 (88%) 0·39 (0·04–3·99) 61 (84%)
Table 4: Linkage to care outcomes in HIV-positive women
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A full cost-eﬀ ectiveness analysis was embedded within 
the trial and results will be reported separately. However, 
researchers and front-line public health professionals 
should consider several factors when trying to replicate or 
implement HBI to scale in other settings. These individuals 
should consider the costs associated with the Mama Packs 
given to the pregnant women as well as the cost of 
integrated laboratory tests. Nevertheless, these costs are 
within the range reported by programmes that showed the 
eﬀ ectiveness of conditional and unconditional cash 
transfers in HIV prevention (de Walque, World Bank, 
unpublished data).36 Also, the testing algorithm comprised 
routine tests oﬀ ered to pregnant women during prenatal 
care. The decision to include a partial intervention (baby 
showers in control group churches) might have led to a 
higher HIV screening rate than would otherwise be 
expected for those communities. We chose this approach 
because ethical concerns related to study designs (eg, 
when control churches do not receive any intervention) are 
known to be barriers against eﬀ ective implementation of 
congregation-based health programmes. The sample size 
and number of study sites were based on infant baptism 
records, but our intervention might have aﬀ ected people 
outside of the study centre, especially in the intervention 
group where on-site integrated testing was oﬀ ered.
Recruitment to the trial ended in 2013, but the 
communities elected to continue the programme owing 
to its popularity in pregnant women, lay health advisers, 
and priests. Each of the participating sites were provided 
with Mama Packs and cost of testing for sickle-cell 
disease is being defrayed by Healthy Sunrise Foundation, 
a non-proﬁ t organisation. HIV testing is provided free 
through our local PEPFAR-supported partner PeTR-GS. 
We are collecting data on HBI activities from the 
40 churches that participated in the initial trial to assess 
sustainability. The US Agency for International 
Development (USAID) and UNICEF have visited various 
communities where HBI is active and are in discussion 
with the Nigerian National AIDS Control Agency to 
disseminate the programme to the states with the highest 
HIV prevalence in the country.
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